BE657451A - - Google Patents
Info
- Publication number
- BE657451A BE657451A BE657451DA BE657451A BE 657451 A BE657451 A BE 657451A BE 657451D A BE657451D A BE 657451DA BE 657451 A BE657451 A BE 657451A
- Authority
- BE
- Belgium
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/12—Triazine radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CS709363 | 1963-12-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE657451A true BE657451A (enExample) | 1965-04-16 |
Family
ID=5419399
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE657451D BE657451A (enExample) | 1963-12-22 | 1964-12-22 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US3350388A (enExample) |
| AT (1) | AT252458B (enExample) |
| BE (1) | BE657451A (enExample) |
| BR (1) | BR6465569D0 (enExample) |
| CH (1) | CH479595A (enExample) |
| DE (1) | DE1245384B (enExample) |
| DK (1) | DK108500C (enExample) |
| ES (1) | ES307376A1 (enExample) |
| FI (1) | FI46389C (enExample) |
| FR (1) | FR1450440A (enExample) |
| GB (1) | GB1050899A (enExample) |
| IT (1) | IT1043755B (enExample) |
| NL (1) | NL6414959A (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1030970A (en) * | 1964-05-15 | 1966-05-25 | Inst Mikrobiologii Im Akad D K | Method for the preparation of 2', 3', 5'-tri-o-acyl-6-azacytidines |
| DE2012888C3 (de) * | 1970-03-14 | 1981-04-02 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | Verfahren zur Herstellung von 5-Azapyrimidinnucleosiden |
| US6943249B2 (en) | 2003-03-17 | 2005-09-13 | Ash Stevens, Inc. | Methods for isolating crystalline Form I of 5-azacytidine |
| US6887855B2 (en) | 2003-03-17 | 2005-05-03 | Pharmion Corporation | Forms of 5-azacytidine |
| US7038038B2 (en) * | 2003-03-17 | 2006-05-02 | Pharmion Corporation | Synthesis of 5-azacytidine |
| US20060014949A1 (en) * | 2004-07-13 | 2006-01-19 | Supergen Inc. | Compositions and formulations of decitabine polymorphs and methods of use thereof |
| WO2009042064A2 (en) | 2007-09-21 | 2009-04-02 | Nektar Therapeutics Al, Corporation | Oligomer-nucleoside phosphate conjugates |
| UA99308C2 (ru) * | 2007-09-26 | 2012-08-10 | Маунт Синай Скул Оф Медсин | Аналог азацитидина и его применение |
| PT2695609T (pt) | 2008-05-15 | 2020-03-02 | Celgene Corp | Formulações orais de análogos da citidina e métodos de utilização dos mesmos |
| WO2010014883A2 (en) | 2008-08-01 | 2010-02-04 | Dr. Reddy's Laboratories Ltd. | Azacitidine process and polymorphs |
| KR101660549B1 (ko) * | 2008-08-08 | 2016-09-27 | 시노팜 타이완 리미티드 | ５―아자시토신 뉴클레오시드 및 이의 유도체의 제조 방법 |
| CN102438588B (zh) | 2009-03-23 | 2015-04-01 | 埃姆比特生物科学公司 | 使用联合治疗法治疗疾病的方法 |
| IT1399195B1 (it) | 2010-03-30 | 2013-04-11 | Chemi Spa | Processo per la sintesi di azacitidina e decitabina |
| MX2013010945A (es) | 2011-03-31 | 2014-03-12 | Celgene Internat Sarl | Sintesis de 5 - azacitidina. |
| LT2833905T (lt) | 2012-04-04 | 2018-07-10 | Halozyme, Inc. | Derinių terapija su hialuronidaze ir į naviką nukreiptu taksanu |
| CN108239128B (zh) | 2016-12-23 | 2019-03-29 | 江苏奥赛康药业股份有限公司 | β-核苷类化合物的制备方法 |
| WO2019222435A1 (en) | 2018-05-16 | 2019-11-21 | Halozyme, Inc. | Methods of selecting subjects for combination cancer therapy with a polymer-conjugated soluble ph20 |
-
0
- GB GB1050899D patent/GB1050899A/en active Active
-
1964
- 1964-12-08 DE DEC34587A patent/DE1245384B/de active Pending
- 1964-12-09 CH CH1590864A patent/CH479595A/de not_active IP Right Cessation
- 1964-12-10 AT AT1047164A patent/AT252458B/de active
- 1964-12-12 FI FI642632A patent/FI46389C/fi active
- 1964-12-14 US US418273A patent/US3350388A/en not_active Expired - Lifetime
- 1964-12-18 DK DK620664AA patent/DK108500C/da active
- 1964-12-19 IT IT27006/64A patent/IT1043755B/it active
- 1964-12-21 ES ES0307376A patent/ES307376A1/es not_active Expired
- 1964-12-22 FR FR999626A patent/FR1450440A/fr not_active Expired
- 1964-12-22 BR BR165569/64A patent/BR6465569D0/pt unknown
- 1964-12-22 NL NL6414959A patent/NL6414959A/xx unknown
- 1964-12-22 BE BE657451D patent/BE657451A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FI46389B (enExample) | 1972-11-30 |
| NL6414959A (enExample) | 1965-06-23 |
| AT252458B (de) | 1967-02-27 |
| FI46389C (fi) | 1973-03-12 |
| ES307376A1 (es) | 1965-05-01 |
| CH479595A (de) | 1969-10-15 |
| FR1450440A (fr) | 1966-06-24 |
| DE1245384B (de) | 1967-07-27 |
| BR6465569D0 (pt) | 1973-08-02 |
| IT1043755B (it) | 1980-02-29 |
| GB1050899A (enExample) | |
| DK108500C (da) | 1967-12-27 |
| US3350388A (en) | 1967-10-31 |